Savara Insider Trades
NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $2.36M
- Shares bought / sold
- 0 / 414.53K
- Net activity
- Net selling $2.4 million
Savara insider activity
Over the last 12 months, Savara insiders reported 47 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $2.4 million worth of stock, for net insider selling of $2.4 million. The largest seller was Lowrance David L, with $2.2 million in reported sales.
The most recent filing shows Parker Braden C. (Chief Commercial Officer) reporting a transaction in 29,323 shares at $5.07 on Sep 24, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SVRA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SVRA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 24, 2026 | Parker Braden C.Chief Commercial Officer | Tax withholding | 29,323 | $148.67K | Form 4 |
| Jul 15, 2026 | Lutz Robert MatthewChief Fin. & Operating Officer | Award | 35,000 | — | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Sale | 394,528 | $2.24M | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 53,387 | $293.63K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Option exercise | 87,650 | $293.63K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 10,114 | $55.63K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Option exercise | 12,500 | $55.63K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 60,057 | $330.31K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Option exercise | 218,750 | $330.31K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 11,491 | $63.20K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Option exercise | 56,937 | $63.20K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 28,928 | $159.10K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Option exercise | 129,350 | $159.10K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 21,682 | $119.25K | Form 4 |
| Jun 22, 2026 | Lowrance David LChief Financial Officer | Option exercise | 75,000 | $119.25K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 16,518 | $83.25K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Option exercise | 24,850 | $83.25K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 11,037 | $55.63K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Option exercise | 12,500 | $55.63K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 9,485 | $47.80K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Option exercise | 43,063 | $47.80K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 31,885 | $160.70K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Option exercise | 130,650 | $160.70K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 23,661 | $119.25K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Option exercise | 75,000 | $119.25K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Tax withholding | 24,174 | $121.84K | Form 4 |
| Mar 18, 2026 | Lowrance David LChief Financial Officer | Option exercise | 80,684 | $121.83K | Form 4 |
| Feb 16, 2026 | McCracken Joseph SDirector | Option exercise | 1,807 | $3.18K | Form 4 |
| Dec 19, 2025 | RAMSAY DAVID ADirector | Sale | 20,000 | $121.22K | Form 4 |
| Dec 16, 2025 | Pauls MatthewCHIEF EXECUTIVE OFFICER | Gift | 128,995 | — | Form 4 |
| Dec 16, 2025 | Lowrance David LChief Financial Officer | Gift | 32,000 | — | Form 4 |
| Dec 14, 2025 | Erickson AnneChief Business Officer | Tax withholding | 62,960 | $435.68K | Form 4 |
| Dec 14, 2025 | McCabe Kathleen R.Chief Legal Officer | Tax withholding | 39,350 | $272.30K | Form 4 |
| Dec 14, 2025 | Pauls MatthewCHIEF EXECUTIVE OFFICER | Tax withholding | 195,705 | $1.35M | Form 4 |
| Dec 14, 2025 | Lowrance David LChief Financial Officer | Tax withholding | 62,960 | $435.68K | Form 4 |
| Dec 14, 2025 | Lutz Robert MatthewChief Operating Officer | Tax withholding | 67,760 | $468.90K | Form 4 |
| Dec 10, 2025 | Pauls MatthewCHIEF EXECUTIVE OFFICER | Gift | 23,629 | — | Form 4 |
| Dec 9, 2025 | McCracken Joseph SDirector | Award | 40,000 | — | Form 4 |
| Dec 9, 2025 | RAMSAY DAVID ADirector | Award | 40,000 | — | Form 4 |
| Dec 9, 2025 | van Es-Johansson AnDirector | Award | 40,000 | — | Form 4 |
| Dec 9, 2025 | Elam Nevan CDirector | Award | 40,000 | — | Form 4 |
| Dec 9, 2025 | Hawkins Richard JDirector | Award | 40,000 | — | Form 4 |
| Dec 4, 2025 | Wasfi YasmineChief Medical Officer | Tax withholding | 21,992 | $140.09K | Form 4 |
| Dec 2, 2025 | Elam Nevan CDirector | Tax withholding | 1,473 | $8.56K | Form 4 |
| Dec 2, 2025 | Elam Nevan CDirector | Option exercise | 5,860 | $8.56K | Form 4 |
| Nov 14, 2025 | Hawkins Richard JDirector | Option exercise | 5,860 | $8.56K | Form 4 |
| Oct 20, 2025 | Wasfi YasmineChief Medical Officer | Award | 35,000 | — | Form 4 |
| Jun 20, 2025 | Hawkins Richard JDirector | Buy | 48,225 | $98.57K | Form 4 |
| May 29, 2025 | McCracken Joseph SDirector | Buy | 10,000 | $20.82K | Form 4 |
| Mar 31, 2025 | RAMSAY DAVID ADirector | Buy | 150,000 | $416.25K | Form 4 |
| Feb 13, 2025 | Lutz Robert MatthewChief Operating Officer | Tax withholding | 38,263 | $108.28K | Form 4 |
| Dec 16, 2024 | Hawkins Richard JDirector | Sale | 8,000 | $26.57K | Form 4 |
| Dec 16, 2024 | Pauls MatthewCHIEF EXECUTIVE OFFICER | Sale | 54,702 | $180.83K | Form 4 |
| Dec 16, 2024 | Lowrance David LChief Financial Officer | Sale | 25,000 | $83.28K | Form 4 |
| Dec 13, 2024 | Pauls MatthewCHIEF EXECUTIVE OFFICER | Tax withholding | 92,593 | $297.22K | Form 4 |
| Dec 13, 2024 | Lowrance David LChief Financial Officer | Tax withholding | 24,350 | $78.16K | Form 4 |
| Dec 13, 2024 | Lowrance David LChief Financial Officer | Gift | 12,000 | — | Form 4 |
| Dec 13, 2024 | Erickson AnneChief Business Officer | Tax withholding | 18,263 | $58.62K | Form 4 |
| Dec 12, 2024 | RAMSAY DAVID ADirector | Award | 40,000 | — | Form 4 |
| Dec 12, 2024 | van Es-Johansson AnDirector | Award | 40,000 | — | Form 4 |
| Dec 12, 2024 | Hawkins Richard JDirector | Award | 40,000 | — | Form 4 |
| Dec 12, 2024 | Lutz Robert MatthewChief Operating Officer | Award | 100,000 | — | Form 4 |
| Dec 12, 2024 | McCracken Joseph SDirector | Award | 40,000 | — | Form 4 |
| Dec 12, 2024 | Elam Nevan CDirector | Award | 40,000 | — | Form 4 |
| Dec 12, 2024 | Pauls MatthewCHIEF EXECUTIVE OFFICER | Award | 400,000 | — | Form 4 |
| Dec 12, 2024 | Pratt Raymond DennisChief Medical Officer | Award | 80,000 | — | Form 4 |
| Dec 12, 2024 | Lowrance David LChief Financial Officer | Award | 100,000 | — | Form 4 |
| Dec 12, 2024 | Parker Braden C.Chief Commercial Officer | Award | 20,000 | — | Form 4 |
| Dec 12, 2024 | Erickson AnneChief Business Officer | Award | 100,000 | — | Form 4 |
| Nov 19, 2024 | McCracken Joseph SDirector | Buy | 20,000 | $59.07K | Form 4 |
| Nov 18, 2024 | RAMSAY DAVID ADirector | Buy | 100,000 | $287.60K | Form 4 |
| Nov 10, 2024 | Pratt Raymond DennisChief Medical Officer | Tax withholding | 49,950 | $198.30K | Form 4 |
| Oct 21, 2024 | Erickson AnneChief Business Officer | Tax withholding | 381 | $1.36K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4